Actos protects heart; Avandia risks persist: studies (Reuters via Yahoo! News)
The diabetes drug Actos cuts the risk of heart attack, stroke and death, but raises the risk of heart failure, according to one study published on Tuesday, while a second confirmed disputed findings that rival Avandia raises heart risks.

VeriChip Kept Quiet On Cancer Link... Yet Were Pretty Vocal On Fake FDA Approvals (Addict 3D)
The Associated Press has a story that got plenty of attention this weekend, pointing out that a series of studies which found that VeriChip's RFID products induced malignant tumors in animals.

BrainStorm Cell Therapeutics Takes Initial Steps Toward FDA Submission (Business Wire via Yahoo! Finance)
NEW YORK & PETACH TIKVAH, Israel----BrainStorm Cell Therapeutics Inc. , a developer of autologous adult stem cell technologies and therapeutics, announced today that the Company has completed a preliminary meeting with representatives of the FDA Office of Cellular, Tissues and Gene Therapies, to discuss BrainStorm's preclinical research program in Parkinson's Disease.